Document

Foreign-Trade Zone (FTZ) 208-New London, Connecticut, Authorization of Production Activity, Sheffield Pharmaceuticals, LLC (Healthcare Products), New London and Norwich, Connecticut

Department of Commerce Foreign-Trade Zones Board [B-36-2021] On April 21, 2021, Sheffield Pharmaceuticals, LLC submitted a notification of proposed production activity to the FT...

Department of Commerce
Foreign-Trade Zones Board
  1. [B-36-2021]

On April 21, 2021, Sheffield Pharmaceuticals, LLC submitted a notification of proposed production activity to the FTZ Board for its facilities within Subzone 208B, in New London and Norwich, Connecticut.

The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (86 FR 24380, May 6, 2021). On August 19, 2021, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including Section 400.14.

Dated: August 19, 2021.

Andrew McGilvray,

Executive Secretary.

[FR Doc. 2021-18193 Filed 8-23-21; 8:45 am]

BILLING CODE 3510-DS-P

Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

86 FR 47294

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Foreign-Trade Zone (FTZ) 208-New London, Connecticut, Authorization of Production Activity, Sheffield Pharmaceuticals, LLC (Healthcare Products), New London and Norwich, Connecticut,” thefederalregister.org (August 24, 2021), https://thefederalregister.org/documents/2021-18193/foreign-trade-zone-ftz-208-new-london-connecticut-authorization-of-production-activity-sheffield-pharmaceuticals-llc-hea.